161 related articles for article (PubMed ID: 9117454)
1. Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.
Moore RD; Chaisson RE
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):223-31. PubMed ID: 9117454
[TBL] [Abstract][Full Text] [Related]
2. Costs of HIV medical care in the era of highly active antiretroviral therapy.
Gebo KA; Chaisson RE; Folkemer JG; Bartlett JG; Moore RD
AIDS; 1999 May; 13(8):963-9. PubMed ID: 10371178
[TBL] [Abstract][Full Text] [Related]
3. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
[TBL] [Abstract][Full Text] [Related]
4. Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols.
Gable CB; Tierce JC; Simison D; Ward D; Motte K
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):413-20. PubMed ID: 8673552
[TBL] [Abstract][Full Text] [Related]
5. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.
Campos NG; Salomon JA; Servoss JC; Nunes DP; Samet JH; Freedberg KA; Goldie SJ
Am J Med; 2007 Mar; 120(3):272-9. PubMed ID: 17349451
[TBL] [Abstract][Full Text] [Related]
7. The cost of care for patients with HIV from the provider economic perspective.
Roberts RR; Kampe LM; Hammerman M; Scott RD; Soto T; Ciavarella GG; Rydman RJ; Gorosh K; Weinstein RA
AIDS Patient Care STDS; 2006 Dec; 20(12):876-86. PubMed ID: 17192152
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of late entry into medical care for patients with HIV infection.
Fleishman JA; Yehia BR; Moore RD; Gebo KA;
Med Care; 2010 Dec; 48(12):1071-9. PubMed ID: 21063228
[TBL] [Abstract][Full Text] [Related]
9. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.
Moore RD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 17 Suppl 1():S38-41. PubMed ID: 9586651
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the cost of medications for ambulatory HIV-infected persons in association with landmark changes in antiretroviral therapy.
Perdue BE; Weidle PJ; Everson-Mays RE; Bozek PS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):354-60. PubMed ID: 9525437
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
13. Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
Sloan CE; Champenois K; Choisy P; Losina E; Walensky RP; Schackman BR; Ajana F; Melliez H; Paltiel AD; Freedberg KA; Yazdanpanah Y;
AIDS; 2012 Jan; 26(1):45-56. PubMed ID: 22008655
[TBL] [Abstract][Full Text] [Related]
14. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
15. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.
Rothbard AB; Metraux S; Blank MB
Psychiatr Serv; 2003 Sep; 54(9):1240-6. PubMed ID: 12954940
[TBL] [Abstract][Full Text] [Related]
16. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
Krentz HB; Gill MJ
HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
[TBL] [Abstract][Full Text] [Related]
17. Consequences of adult HIV infection for outpatient morbidity and treatment costs: a prospective study in a factory clinic in Tanzania.
Kikumbih SN; Isingo R; Boerma JT
Health Policy Plan; 1997 Sep; 12(3):234-9. PubMed ID: 10173404
[TBL] [Abstract][Full Text] [Related]
18. The lifetime cost of current human immunodeficiency virus care in the United States.
Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.
Moore RD; Chaisson RE
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):15-21. PubMed ID: 9377120
[TBL] [Abstract][Full Text] [Related]
20. Contemporary costs of HIV healthcare in the HAART era.
Gebo KA; Fleishman JA; Conviser R; Hellinger J; Hellinger FJ; Josephs JS; Keiser P; Gaist P; Moore RD;
AIDS; 2010 Nov; 24(17):2705-15. PubMed ID: 20859193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
